Zobrazeno 1 - 10 of 62 pro vyhledávání: '"DAVID B PRICE"'
1
Akademický článek
Does mixing inhaler devices lead to unchecked inhaler technique errors in patients with COPD? Findings from the cross-sectional observational MISMATCH study
Autor: Jaime Correia-de-Sousa, David B Price, Sinthia Bosnic-Anticevich, Huib A M Kerstjens, Marjan Kerkhof, Ioanna Tsiligianni, Omar Usmani, P N Richard Dekhuijzen, Janwillem W H Kocks, Lars Dijk, Merijn Driessen, Yoran H Gerritsma, Marika Leving
Publikováno v: BMJ Open Respiratory Research, Vol 10, Iss 1 (2023)
Background Patients with chronic obstructive pulmonary disease (COPD) may be prescribed multiple inhalers that require different techniques for optimal performance. Mixing devices has been associated with poorer COPD outcomes suggesting that it leads
Externí odkaz: https://doaj.org/article/0f2f64adb79943299cbf08fd38dbf040
Zobrazit plný text záznamu
2
Akademický článek
Individualised risk prediction model for exacerbations in patients with severe asthma: protocol for a multicentre real-world risk modelling study
Autor: Richard Beasley, Mohsen Sadatsafavi, David B Price, Wenjia Chen, Christer Janson, Mariko Siyue Koh, Chandra Prakash Yadav, Tae Yoon Lee, Rupsa Roy
Publikováno v: BMJ Open, Vol 13, Iss 3 (2023)
Introduction Severe asthma is associated with a disproportionally high disease burden, including the risk of severe exacerbations. Accurate prediction of the risk of severe exacerbations may enable clinicians to tailor treatment plans to an individua
Externí odkaz: https://doaj.org/article/3ba24455c7264e22bb5d59c7a04e70d0
Zobrazit plný text záznamu
4
Akademický článek
Real-life effectiveness and safety of salbutamol Steri-Neb™ vs. Ventolin Nebules® for exacerbations in patients with COPD: Historical cohort study.
Autor: David B Price, Eran Gefen, Gokul Gopalan, Rosie McDonald, Vicky Thomas, Simon Wan Yau Ming, Emily Davis
Publikováno v: PLoS ONE, Vol 13, Iss 1, p e0191404 (2018)
Ventolin Nebules® (reference product; GlaxoSmithKline) was the first licensed nebulizer solution containing the rapid-onset, short-acting β2-agonist salbutamol. Salbutamol Steri-Neb™ (comparator; Teva Pharmaceuticals, Inc.) has the same chemical
Externí odkaz: https://doaj.org/article/8d72a144638d42cd80121b8a9e728e67
Zobrazit plný text záznamu
5
Akademický článek
Association between blood eosinophil count and risk of readmission for patients with asthma: Historical cohort study.
Autor: Marjan Kerkhof, Trung N Tran, Maarten van den Berge, Guy G Brusselle, Gokul Gopalan, Rupert C M Jones, Janwillem W H Kocks, Andrew Menzies-Gow, Javier Nuevo, Ian D Pavord, Sarang Rastogi, David B Price
Publikováno v: PLoS ONE, Vol 13, Iss 7, p e0201143 (2018)
BACKGROUND:Recent studies have demonstrated an association between high blood eosinophil counts and greater risk of asthma exacerbations. We sought to determine whether patients hospitalized for an asthma exacerbation were at greater risk of readmiss
Externí odkaz: https://doaj.org/article/d8a5810ae42940d4a3d84cfc1769b3b3
Zobrazit plný text záznamu
6
Akademický článek
Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids.
Autor: Samatha Sonnappa, Richard Martin, Elliot Israel, Dirkje Postma, Wim van Aalderen, Annie Burden, Omar S Usmani, David B Price, Respiratory Effectiveness Group, Small Airways Study Group
Publikováno v: PLoS ONE, Vol 12, Iss 6, p e0178112 (2017)
BACKGROUND:Regular use of inhaled corticosteroids (ICS) in patients with obstructive lung diseases has been associated with a higher risk of pneumonia, particularly in COPD. The risk of pneumonia has not been previously evaluated in relation to ICS p
Externí odkaz: https://doaj.org/article/88de6adc17394388ab830d93d0c4dbd9
Zobrazit plný text záznamu
7
Akademický článek
Metabolic Effects Associated with ICS in Patients with COPD and Comorbid Type 2 Diabetes: A Historical Matched Cohort Study.
Autor: David B Price, Richard Russell, Rafael Mares, Anne Burden, Derek Skinner, Helga Mikkelsen, Cherlyn Ding, Richard Brice, Niels H Chavannes, Janwillem W H Kocks, Jeffrey W Stephens, John Haughney
Publikováno v: PLoS ONE, Vol 11, Iss 9, p e0162903 (2016)
Management guidelines for chronic obstructive pulmonary disease (COPD) recommend that inhaled corticosteroids (ICS) are prescribed to patients with the most severe symptoms. However, these guidelines have not been widely implemented by physicians, le
Externí odkaz: https://doaj.org/article/67198140c4c4430290743d1657aa8df0
Zobrazit plný text záznamu
8
Effect of Stepping Up to High-Dose Inhaled Corticosteroids in Patients With Asthma
Autor: Ian D. Pavord, Trung N. Tran, Rupert C. Jones, Javier Nuevo, Maarten van den Berge, Guy G. Brusselle, Andrew N. Menzies-Gow, Derek Skinner, Victoria Carter, Janwillem W.H. Kocks, David B. Price
Publikováno v: Journal of Allergy and Clinical Immunology: In Practice, 11(2), 532-543. American Academy of Allergy, Asthma and Immunology
Journal of Allergy and Clinical Immunology: In Practice, 11(2), 532-543. Elsevier Inc.
Background: It is unclear whether patients with asthma benefit from stepping up to high-dose inhaled corticosteroids (ICSs). Objective: To determine the effectiveness of stepping up to high-dose ICSs. Methods: A historic cohort study of patients with
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7414d6e77ce80ac85a553fdd5d5cd8f
https://research.rug.nl/en/publications/328e7a2e-78d2-4b64-8cda-cca6d248acb4
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje